Part 1/8:
The Unseen Tragedy of Pain Management and Pharmaceutical Profits
The opioid crisis in America continues to unravel chilling truths, shedding light on the complex interplay between drug manufacturers, pharmacy benefit managers (PBMs), and patient experiences. A recent investigation by the New York Times reveals the dark practice of pharmaceutical companies paying PBMs to avoid restrictions on opioid prescriptions, despite the tragic consequences of this behavior.